Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome
Keyword(s):
A 41-year-old woman developed nephrotic syndrome at the age of 32 and was diagnosed with minimal change nephrotic syndrome based on a renal biopsy. Although remission was achieved with administration of prednisolone (PSL) and cyclosporine, the nephrotic syndrome recurred. She was also started on rituximab (RTX). She developed late-onset neutropenia after RTX treatment (R-LON) and improved 17 days later. Although the majority of R-LON cases undergo spontaneous remission, cases of death have been reported. This report is intended to warn about R-LON, since the use of RTX for adult-onset nephrotic syndrome is expected to increase in the future.
Keyword(s):
1987 ◽
Vol 156
(9)
◽
pp. 268-269
◽
Keyword(s):
2013 ◽
Vol 28
(9)
◽
pp. 2306-2312
◽
Keyword(s):
2002 ◽
Vol 39
(5)
◽
pp. 948-957
◽
2007 ◽
Vol 11
(3)
◽
pp. 214-217
◽
2002 ◽
Vol 39
(3)
◽
pp. 503-512
◽